AI

biotech

New target for cancer treatment

Jim Cornall - April 29, 2026

biotech

Researchers identify key protein in inflammatory response to infections

Jim Cornall - April 29, 2026

biotech

Experimental drug protects body from harmful effects of gluten

Jim Cornall - April 29, 2026

biotech

Japanese pharma companies shifting to earlier CDMO outsourcing

Jim Cornall - April 28, 2026

AI

Disrupt.com to invest $100m into UAE AI startups

Jim Cornall - March 3, 2025

AI

Verint expands Global Innovation Center in India

Jim Cornall - February 21, 2025

AI

AI-driven breakthrough could accelerate bioeconomy

Jim Cornall - February 19, 2025

AI

iPRONICS raises €20m to advance optical networking

Jim Cornall - February 4, 2025

AI

VuNet raises $7m to boost global expansion and product innovation

Jim Cornall - January 29, 2025

AI

Pasqal and EDF address electric vehicle charging with quantum computing

Jim Cornall - January 23, 2025

AI

Perciv AI secures €2.5m to expand radar solutions

Jim Cornall - December 23, 2024

AI

NSAIT and ETH Zurich Entrepreneurs launch LogicStar AI

Jim Cornall - December 16, 2024

1...345...7 Page 4 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

New target for cancer treatment

Jim Cornall - April 29, 2026 0

Scientists have uncovered an unexpected way cells can generate cancer-driving proteins—by cutting RNA into shorter, functional fragments rather than following the standard blueprint. This process,...

Researchers identify key protein in inflammatory response to infections

biotech Jim Cornall - April 29, 2026 0

Experimental drug protects body from harmful effects of gluten

biotech Jim Cornall - April 29, 2026 0

Japanese pharma companies shifting to earlier CDMO outsourcing

biotech Jim Cornall - April 28, 2026 0

Promising cell model for dementia research

biotech Jim Cornall - April 28, 2026 0